Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.

Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...

Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

Democrats aren't rushing to play ball with Republicans on a bipartisan health care package after passage of the president's megabill and spending cuts.

As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...

As uncertain tariff news continues to dominate Wall Street, Indiana's economy may be impacted. Jane King, a Nasdaq Analyst, says that with the promised rollout of a new round of tariffs on August 1, ...

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.